Production (Stage)
Fate Therapeutics, Inc.
FATE
$1.28
-$0.125-8.93%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -37.31% | -11.46% | -15.10% | -19.33% | -6.20% |
Total Receivables | 150.63% | 106.86% | 137.47% | -30.13% | -87.79% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -62.68% | -47.20% | -38.30% | 14.03% | -37.81% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -37.06% | -11.95% | -14.80% | -18.56% | -9.94% |
|
|||||
Total Current Assets | -37.06% | -11.95% | -14.80% | -18.56% | -9.94% |
Net Property, Plant & Equipment | -29.33% | -30.04% | -14.35% | -13.52% | -11.85% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -32.66% | -32.60% | -32.60% | -0.16% | -0.48% |
Total Assets | -30.04% | -12.94% | -8.98% | -9.57% | -9.59% |
|
|||||
Total Accounts Payable | -38.06% | 98.45% | 11.27% | -26.79% | -31.35% |
Total Accrued Expenses | -46.28% | -22.41% | -17.38% | -23.13% | 1.68% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.22% | 20.08% | 15.33% | 14.83% | 15.46% |
Total Finance Division Other Current Liabilities | 33.33% | -42.63% | -45.95% | -- | -90.85% |
Total Other Current Liabilities | 33.33% | -42.63% | -45.95% | -- | -90.85% |
Total Current Liabilities | -37.93% | -1.46% | -9.46% | -22.15% | -6.75% |
|
|||||
Total Current Liabilities | -37.93% | -1.46% | -9.46% | -22.15% | -6.75% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -19.74% | -20.04% | -6.96% | -6.61% | -6.27% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 94.05% | 315.82% | 347.50% | 78.51% | 27.86% |
Total Liabilities | -23.31% | -11.49% | -5.93% | -10.32% | -5.94% |
|
|||||
Common Stock & APIC | 2.24% | 8.63% | 8.69% | 8.64% | 8.93% |
Retained Earnings | -13.96% | -15.37% | -15.26% | -15.66% | -17.77% |
Treasury Stock & Other | 198.45% | 1,686.67% | 267.33% | 28.11% | 69.97% |
Total Common Equity | -32.32% | -13.49% | -10.04% | -9.31% | -10.76% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | -32.32% | -13.49% | -10.04% | -9.31% | -10.76% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -32.32% | -13.49% | -10.04% | -9.31% | -10.76% |
|